Iris Uniroma1 Prodmetadata only
The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of age
non-small cell lung cancer, elderly patient, anti-pd1 treatment, immunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 652989
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.